우울증의 생체 지표

키워드

참고문헌 (160)

1. Sadock BJ, "Synopsis of psychiatiry" (2007), Lippincott Williams & Wilkins
2. Kessler RC, "Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication", Arch Gen Psychiatry, 62, pp.593~602 (2005)
3. Palazidou E, "The neurobiology of depression", Br Med Bull, 101, pp.127~145 (2012)
4. Maletic V, "Neurobiology of depression: an integrated view of key findings", Int J Clin Pract, 61, pp.2030~2040 (2007)
5. Marije aan het Rot M, "Neurobiological mechanisms in major depressive disorder", CMAJ, 180, pp.305~313 (2009)
6. McGorry P, "Biomarkers and clinical staging in psychiatry", World Psychiatry, 13, pp.211~223 (2014)
7. Nestler EJ, "Neurobiology of depression", Neuron, 34, pp.13~25 (2002)
8. Hirschfeld RM, "History and evolution of the monoamine hypothesis of depression", J Clin Psychiatry, 61(Suppl 6), pp.4~6 (2000)
9. Rodriguez-Herreros B, "Shifted visual feedback of the hand affects reachability judgments in interception", Vision Res, 88, pp.30~37 (2013)
10. Ruhe HG, "Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans : A meta-analysis of monoamine depletion studies", Mol Psychiatry, 12, pp.331~359 (2007)
11. Cools R, "Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces", Psychopharmacology(Berl), 180, pp.670~679 (2005)
12. Jans LAW, "Serotonergic vulnerability and depression : assumptions, experimental evidence and implications", Mol Psychiatry, 12, pp.522~543 (2007)
13. Barnes DE, "Depressive symptoms, vascular disease, and mild cognitive impairment-Findings from the cardiovascular health study", Arch Gen Psychiatry, 63, pp.273~280 (2006)
14. Lesch KP, "Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region", Science, 274, pp.1527~1531 (1996)
15. Levinson DF, "The genetics of depression: a review", Biol Psychiatry, 60, pp.84~92 (2006)
16. methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression, "Arch Gen Psychiatry", 2004, 556~563
17. Wurtman RJ, "Genes, stress, and depression", Metabolism, 54, pp.16~19 (2005)
18. Atkinson AJ, "Biomarkers and surrogate endpoints : Preferred definitions and conceptual framework", Clin Pharmacol Ther, 69, pp.89~95 (2001)
19. Schmidt HD, "Functional biomarkers of depression : diagnosis, treatment, and pathophysiology", Neuropsychopharmacology, 36, pp.2375~2394 (2011)
20. Schneider B, "Biomarkers for major depression and its delineation from neurodegenerative disorders", Prog Neurobiol, 95, pp.703~717 (2011)
21. Scott LV, "Vasopressin as a target for antidepressant development : an assessment of the available evidence", J Affect Disord, 72, pp.113~124 (2002)
22. Board F, "Psychological stress and endocrine functions; blood levels of adrenocortical and thyroid hormones in acutely disturbed patients", Psychosom Med, 18, pp.324~333 (1956)
23. Deuschle M, "Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls", J Clin Endocrinol Metab, 82, pp.234~238 (1997)
24. Linkowski P, "The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness", J Clin Endocrinol Metab, 61, pp.429~438 (1985)
25. Mortola JF, "Pulsatile rhythms of adrenocorticotropin(ACTH)and cortisol in women with endogenous depression : evidence for increased ACTH pulse frequency", J Clin Endocrinol Metab, 65, pp.962~968 (1987)
26. Nemeroff CB, "Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin", Br J Psychiatry, 158, pp.59~63 (1991)
27. Nemeroff CB, "Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients", Science, 226, pp.1342~1344 (1984)
28. Raadsheer FC, "Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients", Neuroendocrinology, 60, pp.436~444 (1994)
29. Nemeroff CB, "Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims", Arch Gen Psychiatry, 45, pp.577~579 (1988)
30. Axelson DA, "In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology : relationship to dexamethasone suppression test results in patients", Psychiatry Res, 44, pp.63~70 (1992)
31. Krishnan KR, "Pituitary size in depression", J Clin Endocrinol Metab, 72, pp.256~259 (1991)
32. Nemeroff CB, "Adrenal gland enlargement in major depression. A computed tomographic study", Arch Gen Psychiatry, 49, pp.384~387 (1992)
33. Rubin RT, "Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment", Arch Gen Psychiatry, 52, pp.213~218 (1995)
34. Holsboer F, "Antidepressants and hypothalamic-pituitary-adrenocortical regulation", Endocr Rev, 17, pp.187~205 (1996)
35. Zobel AW, "Effects of the high-affinity corticotropinreleasing hormone receptor 1 antagonist R121919 in major depression : the first 20 patients treated", J Psychiatr Res, 34, pp.171~181 (2000)
36. Tichomirowa M, "Endocrine disturbances in depression", J Endocrinol Invest, 28, pp.89~99 (2005)
37. Vandoolaeghe E, "Hypothalamic-pituitary-thyroid-axis function in treatment resistant depression", J Affect Disord, 43, pp.143~150 (1997)
38. Kastin AJ, "Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone", Lancet, 2, pp.740~742 (1972)
39. Prange AJ Jr, "Effects of thyrotropin-releasing hormone in depression", Lancet, 2, pp.999~1002 (1972)
40. Bartalena L, "Nocturnal serum thyrotropin(TSH)surge and the TSH response to TSH-releasing hormone : dissociated behavior in untreated depressives", J Clin Endocrinol Metab, 71, pp.650~655 (1990)
41. Gold MS, "The TRH test in the diagnosis of major and minor depression", Psychoneuroendocrinology, 6, pp.159~169 (1981)
42. Nemeroff CB, "Antithyroid antibodies in depressed patients", Am J Psychiatry, 142, pp.840~843 (1985)
43. Haggerty JJ Jr, "The presence of antithyroid antibodies in patients with affective and nonaffective psychiatric disorders", Biol Psychiatry, 27, pp.51~60 (1990)
44. Musselman DL, "Depression and endocrine disorders: focus on the thyroid and adrenal system", Br J Psychiatry Suppl, pp.123~128 (1996)
45. Altshuler LL, "Does thyroid supplementation accelerate tricyclic antidepressant response? A review and metaanalysis of the literature", Am J Psychiatry, 158, pp.1617~1622 (2001)
46. Pinna G, "Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation", Biol Psychiatry, 54, pp.1049~1059 (2003)
47. Steiger A, "Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery", J Affect Disord, 16, pp.189~195 (1989)
48. Jarrett DB, "Recurrent depression is associated with a persistent reduction in sleeprelated growth hormone secretion", Arch Gen Psychiatry, 47, pp.113~118 (1990)
49. Rubin RT, "Neuroendocrine aspects of primary endogenous depression. X: Serum growth hormone measures in patients and matched control subjects", Biol Psychiatry, 27, pp.1065~1082 (1990)
50. Voderholzer U, "Profiles of spontaneous 24-hour and stimulated growth hormone secretion in male patients with endogenous depression", Psychiatry Res, 47, pp.215~227 (1993)
51. Sakkas PN, "Growth hormone secretion during sleep in male depressed patients", Prog Neuropsychopharmacol Biol Psychiatry, 22, pp.467~483 (1998)
52. Lesch KP, "Insulin-like growth factor I in depressed patients and controls", Acta Psychiatr Scand, 78, pp.684~688 (1988)
53. Rupprecht R, "Psychoneuroendocrine research in depression. I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test", J Neural Transm, 75, pp.167~178 (1989)
54. Deuschle M, "Insulin-like growth factor-I(IGF-I)plasma concentrations are increased in depressed patients", Psychoneuroendocrinology, 22, pp.493~503 (1997)
55. Franz B, "Insulin-like growth factor 1 and growth hormone binding protein in depression : a preliminary communication", J Psychiatr Res, 33, pp.121~127 (1999)
56. Gerner RH, "Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients", Brain Res, 238, pp.298~302 (1982)
57. Rubinow DR, "Cerebrospinal f luid somatostatin a nd psychiatric illness", Biol Psychiatry, 21, pp.341~365 (1986)
58. Doran AR, "CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients", Arch Gen Psychiatry, 43, pp.365~369 (1986)
59. Chappell PB, "Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress", J Neurosci, 6, pp.2908~2914 (1986)
60. Sunderland T, "CSF somatostatin in patients with Alzheimer’s disease, older depressed patients, and age-matched control subjects", Am J Psychiatry, 144, pp.1313~1316 (1987)
61. Molchan SE, "CSF monoamine metabolites and somatostatin in Alzheimer’s disease and major depression", Biol Psychiatry, 29, pp.1110~1118 (1991)
62. Heuser I, "Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls : response to amitriptyline treatment", Depress Anxiety, 8, pp.71~79 (1998)
63. 63)Matussek N, "Effect of clonidine on growth hormone release in psychiatric patients and controls", Psychiatry Res, 2, pp.25~36 (1980)
64. Checkley SA, "The GH response to clonidine in endogenous as compared with reactive depression", Psychol Med, 14, pp.773~777 (1984)
65. Siever LJ, "Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls", Psychiatry Res, 6, pp.171~183 (1982)
66. Mokrani M, "Multihormonal responses to clonidine in patients with affective and psychotic symptoms", Psychoneuroendocrinology, 25, pp.741~752 (2000)
67. Ryan ND, "Stimulatory tests of growth hormone secretion in prepubertal major depression : depressed versus normal children", J Am Acad Child Adolesc Psychiatry, 33, pp.824~833 (1994)
68. Dahl RE, "Low growth hormone response to growth hormone-releasing hormone in child depression", Biol Psychiatry, 48, pp.981~988 (2000)
69. Birmaher B, "Growth hormone secretion in children and adolescents at high risk for major depressive disorder", Arch Gen Psychiatry, 57, pp.867~872 (2000)
70. Rivier C, "Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat", Endocrinology, 117, pp.2478~2482 (1985)
71. MacLusky NJ, "Immunocytochemical evidence for direct synaptic connections between corticotrophin-releasing factor(CRF)and gonadotrophin-releasing hormone(GnRH)-containing neurons in the preoptic area of the rat", Brain Res, 439, pp.391~395 (1988)
72. Young EA, "The hypothalamic-pituitary-gonadal axis in mood disorders", Endocrinol Metab Clin North Am, 31, pp.63~78 (2002)
73. Attardi B, "Glucocorticoid repression of gonadotropin-releasing hormone gene expression and secretion in morphologically distinct subpopulations of GT1-7 cells", Mol Cell Endocrinol, 131, pp.241~255 (1997)
74. Chandran UR, "Glucocorticoid receptor-mediated repression of gonadotropin-releasing hormone promoter activity in GT1 hypothalamic cell lines", Endocrinology, 134, pp.1467~1474 (1994)
75. Harlow BL, "Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause : the Harvard Study of Moods and Cycles", Arch Gen Psychiatry, 60, pp.29~36 (2003)
76. Schweiger U, "Testosterone, gonadotropin, and cortisol secretion in male patients with major depression", Psychosom Med, 61, pp.292~296 (1999)
77. Steiger A, "Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission", J Psychiatr Res, 25, pp.169~177 (1991)
78. Pope HG Jr, "Testosterone gel supplementation for men with refractory depression : a randomized, placebo-controlled trial", Am J Psychiatry, 160, pp.105~111 (2003)
79. Pope HG Jr, "Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment", J Clin Psychopharmacol, 30, pp.126~134 (2010)
80. Schwartz MW, "Regulation of appetite and body weight", Hosp Pract, 109, pp.109~1119 (1997)
81. Deuschle M, "Plasma leptin in depressed patients and healthy controls", Horm Metab Res, 28, pp.714~717 (1996)
82. Jow GM, "Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia", J Affect Disord, 90, pp.21~27 (2006)
83. Kraus T, "Low leptin levels but normal body mass indices in patients with depression or schizophrenia", Neuroendocrinology, 73, pp.243~247 (2001)
84. Atmaca M, "Serum leptin and cholesterol values in suicide attempters", Neuropsychobiology, 45, pp.124~127 (2002)
85. Westling S, "Low CSF leptin in female suicide attempters with major depression", J Affect Disord, 81, pp.41~48 (2004)
86. Lu XY, "The leptin hypothesis of depression: a potential link between mood disorders and obesity?", Curr Opin Pharmacol, 7, pp.648~652 (2007)
87. Faith MS, "Obesity-depression associations in the population", J Psychosom Res, 53, pp.935~942 (2002)
88. McElroy SL, "Are mood disorders and obesity related? A review for the mental health professional", J Clin Psychiatry, 65, pp.634~635 (2004)
89. Simon GE, "Association between obesity and psychiatric disorders in the US adult population", Arch Gen Psychiatry, 63, pp.824~830 (2006)
90. Stunkard AJ, "Depression and obesity", Biol Psychiatry, 54, pp.330~337 (2003)
91. Irwin MR, "Depressive disorders and immunity : 20 years of progress and discovery", Brain Behav Immun, 21, pp.374~383 (2007)
92. Bremmer MA, "Inflammatory markers in late-life depression : results from a population-based study", J Affect Disord, 106, pp.249~255 (2008)
93. Penninx BW, "Inflammatory markers and depressed mood in older persons : results from the Health, Aging and Body Composition study", Biol Psychiatry, 54, pp.566~572 (2003)
94. Tuglu C, "Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder", Psychopharmacology(Berl), 170, pp.429~433 (2003)
95. Zorrilla EP, "The relationship of depression and stressors to immunological assays : a meta-analytic review", Brain Behav Immun, 15, pp.199~226 (2001)
96. McNally L, "Inflammation, glutamate, and glia in depression : a literature review", CNS Spectr, 13, pp.501~510 (2008)
97. Pace TW, "Cytokine-effects on glucocorticoid receptor function : relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression", Brain Behav Immun, 21, pp.9~19 (2007)
98. Muller N, "The cyclooxygenase-2inhibitor celecoxib has therapeutic effects in major depression : results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine", Mol Psychiatry, 11, pp.680~684 (2006)
99. Pasco JA, "Clinical implications of the cytokine hypothesis of depression : the association between use of statins and aspirin and the risk of major depression", Psychother Psychosom, 79, pp.323~325 (2010)
100. Stafford L, "The Use of Statins After a Cardiac Intervention Is Associated With Reduced Risk of Subsequent Depression: Proof of Concept for the Inflammatory and Oxidative Hypotheses of Depression?", J Clin Psychiatry, 72, pp.1229~1235 (2011)
101. Haddy N, "Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations : STANISLAS cohort", Eur J Hum Genet, 13, pp.109~117 (2005)
102. Stahl LA, "The role of omega-3 fatty acids in mood disorders", Current Opinion in Investigational Drugs, 9, pp.57~64 (2008)
103. Hibbeln JR, "Fish consumption and major depression", Lancet, 351, pp.1213~ (1998)
104. Hibbeln JR, "Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: a cross-national, ecological analysis", J Affect Disord, 69, pp.15~29 (2002)
105. Noaghiul S, "Cross-national comparisons of seafood consumption and rates of bipolar disorders", Am J Psychiatry, 160, pp.2222~2227 (2003)
106. Frasure-Smith, "Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes", Biol Psychiatry, 55, pp.1201~ (2004)
107. Hakkarainen R, "Is low dietary intake of omega-3fatty acids associated with depression?", Am J Psychiatry, 161, pp.567~569 (2004)
108. Jacka E, "Dietary omega-3 fatty acids and depression in a community sample", Nutr Neurosci, 7, pp.101~106 (2004)
109. McNamara RK, "Selective deficits in the omega-3fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder", Biol Psychiatry, 62, pp.17~24 (2007)
110. Raeder MB, "Associations between cod liver oil use and symptoms of depression : The Hordaland Health Study", J Affect Disord, 101, pp.245~249 (2007)
111. Sanchez-Villegas A, "Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study", Eur J Nutr, 46, pp.337~346 (2007)
112. Schins A, "Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients", Acta Psychiatr Scand, 115, pp.35~40 (2007)
113. Silvers KM, "Fish consumption and self-reported physical and mental health status", Public Health Nutr, 5, pp.427~431 (2002)
114. Suzuki S, "Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer", Psychooncology, 13, pp.787~793 (2004)
115. Tanskanen A, "Fish consumption, depression, and suicidality in a general population", Arch Gen Psychiatry, 58, pp.512~513 (2001)
116. Timonen M, "Fish consumption and depression : the Northern Finland 1966 birth cohort study", J Affect Disord, 82, pp.447~452 (2004)
117. Chen ZY, "Genetic variant BDNF(Val66Met) polymorphism alters anxiety-related behavior", Science, 314, pp.140~143 (2006)
118. Duman RS, "A neurotrophic model for stress-related mood disorders", Biol Psychiatry, 59, pp.1116~1127 (2006)
119. Schule C, "Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone", CRH test results in depressed patients, 2006, pp.31, 1019~1025
120. Sen S, "Meta-analysis of serum brain-derived neurotrophic factor (BDNF) levels in depression and antidepressant treatment", Biol Psychiatry, 63, pp.98S~S (2008)
121. Lee BH, "Decreased plasma BDNF level in depressive patients", J Affect Disord, 101, pp.239~244 (2007)
122. Sen S, "Serum brain-derived neurotrophic factor, depression, and antidepressant medications : meta-analyses and implications", Biol Psychiatry, 64, pp.527~532 (2008)
123. Malberg JE, "Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus", J Neurosci, 20, pp.9104~9110 (2000)
124. Shimizu E, "Alterations of serum levels of brain-derived neurotrophic factor(BDNF)in depressed patients with or without antidepressants", Biol Psychiatry, 54, pp.70~75 (2003)
125. Manji HK, "The cellular neurobiology of depression", Nat Med, 7, pp.541~547 (2001)
126. Brunoni AR, "A systematic review and meta-analysis of clinical studies on major depression and BDNF levels : implications for the role of neuroplasticity in depression", Int J Neuropsychopharmacol, 11, pp.1169~1180 (2008)
127. Piccinni A, "Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy", Eur Neuropsychopharmacol, 19, pp.349~355 (2009)
128. Lang UE, "Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation", Psychopharmacology (Berl), 187, pp.56~59 (2006)
129. Zanardini R, "Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients", J Affect Disord, 91, pp.83~86 (2006)
130. Egan MF, "The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function", Cell, 112, pp.257~269 (2003)
131. Hariri AR, "Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance", J Neurosci, 23, pp.6690~6694 (2003)
132. Hashimoto K, "Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions", Psychiatry Clin Neurosci, 64, pp.341~357 (2010)
133. Rybakowski JK, "BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia", Pharmacogenomics, 9, pp.1589~1593 (2008)
134. Gyekis JP, "No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis", Am J Med Genet B Neuropsychiatr Genet, 162B, pp.61~70 (2013)
135. Lin PY, "Decreased glial cell line-derived neurotrophic factor levels in patients with depression : A meta-analytic study", J Psychiatr Res, 63, pp.20~27 (2015)
136. Golden JP, "Expression of neurturin, GDNF, and their receptors in the adult mouse CNS", J Comp Neurol, 398, pp.139~150 (1998)
137. Christophersen NS, "Midbrain expression of Delta-like 1 hornologue is regulated by GDNF and is associated with dopaminergic differentiation", Exp Neurol, 204, pp.791~801 (2007)
138. Ducray A, "GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon", Brain Res, 1069, pp.104~112 (2006)
139. Hochstrasser T, "Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2, 3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices", Neuroscience, 184, pp.128~138 (2011)
140. Jaumotte JD, "Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures", J Neurosci Res, 92, pp.1425~1433 (2014)
141. Takebayashi M, "Decreased levels of whole blood glial cell line-derived neurotrophic factor(GDNF)in remitted patients with mood disorders", Int J Neuropsychopharmacol, 9, pp.607~612 (2006)
142. Cardoso TD, "Neurotrophic factors, clinical features and gender differences in depression", Neurochem Res, 39, pp.1571~1578 (2014)
143. Diniz BS, "Circulating glial-derived neurotrophic factor is reduced in late-life depression", J Psychiatr Res, 46, pp.135~139 (2012)
144. Rosa AR, "Increased serum glial cell linederived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder", Neurosci Lett, 407, pp.146~150 (2006)
145. Wang XQ, "Association study between plasma GDNF and cognitive function in late-onset depression", J Affect Disord, 132, pp.418~421 (2011)
146. Rao U, "Biomarkers in pediatric depression", Depress Anxiety, 30, pp.787~791 (2013)
147. Pillai V, "A meta-analysis of electroencephalographic sleep in depression : evidence for genetic biomarkers", Biol Psychiatry, 70, pp.912~919 (2011)
148. Sheline YI, "Untreated depression and hippocampal volume loss", Am J Psychiatry, 160, pp.1516~1518 (2003)
149. Frodl TS, "Depression-related variation in brain morphology over 3 years: effects of stress?", Arch Gen Psychiatry, 65, pp.1156~1165 (2008)
150. Hickie IB, "Psychomotor slowing in older patients with major depression : Relationships with blood flow in the caudate nucleus and white matter lesions", Psychiatry Research-Neuroimaging, 155, pp.211~220 (2007)
151. Kalmar JH, "Preliminary evidence for progressive prefrontal abnormalities in adolescents and young adults with bipolar disorder", J Int Neuropsychol Soc, 15, pp.476~481 (2009)
152. Fitzgerald PB, "A meta-analytic study of changes in brain activation in depression", Hum Brain Mapp, 29, pp.683~695 (2008)
153. Mayberg HS, "Modulating dysfunctional limbic-cortical circuits in depression : towards development of brainbased algorithms for diagnosis and optimised treatment", Br Med Bull, 65, pp.193~207 (2003)
154. Fales CL, "Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression", Biol Psychiatry, 63, pp.377~384 (2008)
155. heline YI, "Neuroimaging studies of mood disorder effects on the brain", Biol Psychiatry, 54, pp.338~352 (2003)
156. Siegle GJ, "Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression : related and independent features", Biol Psychiatry, 61, pp.198~209 (2007)
157. Dannlowski U, "Reduced amygdala-prefrontal coupling in major depression : association with MAOA genotype and illness severity", Int J Neuropsychopharmacol, 12, pp.11~22 (2009)
158. Greicius MD, "Resting-State Functional Connectivity in Major Depression : Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus", Biol Psychiatry, 62, pp.429~437 (2007)
159. Pajer K, "Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression", Transl Psychiatry, 2, pp.e101~ (2012)
160. Souslova T, "Personalized medicine in Alzheimer’s disease and depression", Contemp Clin Trials, 36, pp.616~623 (2013)

관련 논문AI추천